American Journal of Cardiovascular Drugs

Impaired Glucose Metabolism in Patients with Heart Failure: Pathophysiology and Possible Treatment Strategies
pp. 269-280(12)
Authors: Alexander Tenenbaum; Enrique Z. Fisman

Interactions Between Grapefruit Juice and Cardiovascular Drugs
pp. 281-297(17)
Authors: David G. Bailey; George K. Dresser

Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention: Recommendations of the HDL Forum1 1 Affiliation details for individual members of the HDL Forum are available in the Acknowledgments section.
pp. 299-314(16)
Authors: Juan F. Ascaso; Arturo Fernández-Cruz; Pedro González Santos; Antonio Hernández Mijares; Alipio Mangas Rojas; Jesus Millán; Luis Felipe Pallardo; Juan Pedro-Botet; Francisco Pérez-Jiménez; Gonzalo Pía; Xavier Pintó; Ignacio Plaza; Juan Rubiés-Prat

HIV-Related Cardiovascular Disease and Drug Interactions
pp. 315-324(10)
Authors: Kinjal A. Nanavati; Stacy D. Fisher; Tracie L. Miller; Steven E. Lipshultz

Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients
pp. 325-333(9)
Authors: George Dranitsaris; Susan R. Kahn; Carmine Stumpo; Thomas W. Paton; Josee Martineau; Reginald Smith; Jeffrey S. Ginsberg

Clinical Experience with Perindopril in Elderly Hypertensive Patients: A Subgroup Analysis of a Large Community Trial
pp. 335-341(7)
Authors: Joel M. Neutel; Michael A. Weber; Stevo Julius; Jay N. Cohn; Prasad Turlapaty; Yannan Shen; Weinong Guo; Alicia Batchelor; Hjalmar Lagast